What is the scope of this report?

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry. Read More

Which segments covered in this report?

Market is segmented by Types, Applications, Technology, End-use Industries, and Regions. Read More

What are the key factors covered in this report?

The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions. Read More

Cutaneous Leishmaniasis Drugs Market

Q: Does this report offer customization?

Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs. Read More

Report Code : 286276
Industry : Healthcare and Pharmaceuticals
Published On : Aug 2019
Pages : 105
Publisher : Verified Market Intelligence
Format:

What is Cutaneous Leishmaniasis Drugs?
Cutaneous leishmaniasis is a parasitic disease. It is spread by the female sandfly, which occurs in the new world and the old world. The drugs approved for cutaneous leishmaniasis treatment include fluconazole, tablet azole antifungals-systemic, Diflucan, Diflucan tablet azole antifungals-systemic, impavido, miltefosine capsule, pentam 300 solution, reconstituted, off and pentamidine 300 mg solution for injection antiprotozoal agents are.

Global Cutaneous Leishmaniasis Drugs Market Outlook
About 95% of cutaneous leishmaniasis cases occur in the Americas, the Mediterranean Basin, the Middle East, and Central Asia. In 2017 over 95% of new cutaneous leishmaniasis cases occurred in six countries: Brazil, Colombia, Afghanistan, Algeria, Iran, Iraq, and the Syrian Arab Republic. According to the World Health Organization, it is anticipated that between 600 000 to 1 million new cases arise worldwide yearly.
Cutaneous leishmaniasis cases have increased intensely in Syria and neighbouring countries due to the conflict-related displacement of Syrians. Advancement in drug therapies to provide a new treatment for cutaneous leishmaniasis. The current strategy is to control this disease mainly based on chemotherapy, presently used therapies against cutaneous leishmaniasis lead to complete cure. However, they associate with many limitations, efficacy remains hindered by the patient's age and immune system.
Lack of awareness, high cost of treatment and prolong treatment span hinders the growth of the market. World Health Organization (WHO) considers leishmaniasis to be one of the main neglected diseases in the world, affecting mostly the poor population of underdeveloped and developing countries.

Global Cutaneous Leishmaniasis Drugs Market Competitive Landscape
The "Global Cutaneous Leishmaniasis Drugs Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as GlaxoSmithKline, Novartis, Sanofi, Gilead Sciences, Bristol-Myers Squibb, Albert David, Profounda, Knight Therapeutics and Johnson & Johnson. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.

1. INTRODUCTION OF GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET

1.1. Overview of the Market

1.2. Scope of Report

1.3. Assumptions


2. EXECUTIVE SUMMARY


3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1. Data Mining

3.2. Validation

3.3. Primary Interviews

3.4. List of Data Sources


4. GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET OUTLOOK

4.1. Overview

4.2. Market Dynamics

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Porters Five Force Model

4.4. Value Chain Analysis

5. GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET, BY PRODUCT TYPE

5.1. Overview

5.2. Pentavalent Antimonials

5.3. Antifungal Drugs

5.4. Anti-Leishmanial/Antimicrobial Drugs


6. GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET, BY DISTRIBUTION CHANNEL

6.1. Overview

6.2. Hospitals Pharmacies

6.3. Retail Pharmacies

6.4. Online Pharmacies


7. GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET, BY GEOGRAPHY

7.1. Overview

7.2. North America 

7.2.1. U.S.

7.2.2. Canada

7.2.3. Mexico

7.3. Europe

7.3.1. Germany

7.3.2. U.K.

7.3.3. France

7.3.4. Rest of Europe

7.4. Asia Pacific

7.4.1. China

7.4.2. Japan

7.4.3. India

7.4.4. Rest of Asia Pacific

7.5. Rest of the World

7.5.1. Latin America 

7.5.2. Middle East & Africa 


8. GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET COMPETITIVE LANDSCAPE

8.1. Overview

8.2. Company Market Ranking 

8.3. Key Development Strategies

9. COMPANY PROFILES

9.1. GlaxoSmithKline

10.1.1 Overview

10.1.2 Financial Performance

10.1.3 Product Outlook

10.1.4 Key Developments

9.2. Novartis

9.2.1. Overview

9.2.2. Financial Performance

9.2.3. Product Outlook

9.2.4. Key Developments

9.3. Sanofi

9.3.1. Overview

9.3.2. Financial Performance

9.3.3. Product Outlook

9.3.4. Key Developments

9.4. Gilead Sciences

9.4.1. Overview

9.4.2. Financial Performance

9.4.3. Product Outlook

9.4.4. Key Developments

9.5. Bristol-Myers Squibb

9.5.1. Overview

9.5.2. Financial Performance

9.5.3. Product Outlook

9.5.4. Key Developments

9.6. Albert David

9.6.1. Overview

9.6.2. Financial Performance

9.6.3. Product Outlook

9.6.4. Key Developments

9.7. Profounda

9.7.1. Overview

9.7.2. Financial Performance

9.7.3. Product Outlook

9.7.4. Key Developments

9.8. Knight Therapeutics

9.8.1. Overview

9.8.2. Financial Performance

9.8.3. Product Outlook

9.8.4. Key Developments

9.9. Johnson & Johnson

9.9.1. Overview

9.9.2. Financial Performance

9.9.3. Product Outlook

9.9.4. Key Developments


10. Appendix

10.1. Related Reports

Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

Price : US$ 2450	Date : Feb 2024
Category : Healthcare and Pharmaceuticals	Pages : 221

Global Antibiotic Drugs Market (2024 Edition): Analysis By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoroquinolone, Others), Spectrum (Broad, Narrow), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

Price : US$ 2450	Date : Feb 2024
Category : Healthcare and Pharmaceuticals	Pages : 260

Global Sex Hormone Drugs Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030

Price : US$ 3500	Date : Dec 2023
Category : Healthcare and Pharmaceuticals	Pages : 115

Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

Price : US$ 2450	Date : Dec 2023
Category : Healthcare and Pharmaceuticals	Pages : 230

Global Microecological Drugs Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030

Price : US$ 3500	Date : Nov 2023
Category : Healthcare and Pharmaceuticals	Pages : 100

Choose License Type

Happy To Assist You

We will be happy to help you find what you need. Please call us or write to us:

Email
sales@worldwidemarketreports.com
United States Of America

+1-415-871-0703
United Kingdom

+44-203-289-4040
Japan

+81-50-5539-1737
INDIA

+91-848-285-0837

Frequently Asked Questions

What does this report covers?

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.

Does this report estimates the current market size?

The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.

Does the report provides Market Size in terms of – Value (US$ Mn) and Volume (Thousands Units)?

The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).

What are the key segments offered in this report?

Market is segmented by:

Which market dynamics covered in this report?

The report share key insights on the following:

It helps the businesses in making investments decisions.

Does this report offer customization?

Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.